CN101495185A - 用于治疗外层视网膜病症的单胺氧化酶抑制剂 - Google Patents

用于治疗外层视网膜病症的单胺氧化酶抑制剂 Download PDF

Info

Publication number
CN101495185A
CN101495185A CNA2007800283812A CN200780028381A CN101495185A CN 101495185 A CN101495185 A CN 101495185A CN A2007800283812 A CNA2007800283812 A CN A2007800283812A CN 200780028381 A CN200780028381 A CN 200780028381A CN 101495185 A CN101495185 A CN 101495185A
Authority
CN
China
Prior art keywords
administration
alkyl
retina
unsubstituted
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800283812A
Other languages
English (en)
Chinese (zh)
Inventor
R·小科里尔
M·卡平
J·扬尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Research LLC
Original Assignee
Alcon Manufacturing Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Manufacturing Ltd filed Critical Alcon Manufacturing Ltd
Publication of CN101495185A publication Critical patent/CN101495185A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CNA2007800283812A 2006-07-28 2007-07-27 用于治疗外层视网膜病症的单胺氧化酶抑制剂 Pending CN101495185A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82073506P 2006-07-28 2006-07-28
US60/820,735 2006-07-28

Publications (1)

Publication Number Publication Date
CN101495185A true CN101495185A (zh) 2009-07-29

Family

ID=38743901

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800283812A Pending CN101495185A (zh) 2006-07-28 2007-07-27 用于治疗外层视网膜病症的单胺氧化酶抑制剂

Country Status (11)

Country Link
US (1) US20110160308A1 (cg-RX-API-DMAC7.html)
EP (1) EP2046451A1 (cg-RX-API-DMAC7.html)
JP (1) JP2009544740A (cg-RX-API-DMAC7.html)
KR (1) KR20090034365A (cg-RX-API-DMAC7.html)
CN (1) CN101495185A (cg-RX-API-DMAC7.html)
AU (1) AU2007278837A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0714985A2 (cg-RX-API-DMAC7.html)
CA (1) CA2658246A1 (cg-RX-API-DMAC7.html)
MX (1) MX2009000792A (cg-RX-API-DMAC7.html)
WO (1) WO2008014457A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200900234B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109251155A (zh) * 2017-07-14 2019-01-22 广东东阳光药业有限公司 α-氨基酰胺衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
EP0808160A1 (en) * 1995-02-10 1997-11-26 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
GB9515412D0 (en) * 1995-07-27 1995-09-27 Pharmacia Spa 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109251155A (zh) * 2017-07-14 2019-01-22 广东东阳光药业有限公司 α-氨基酰胺衍生物及其用途

Also Published As

Publication number Publication date
BRPI0714985A2 (pt) 2013-07-30
EP2046451A1 (en) 2009-04-15
AU2007278837A1 (en) 2008-01-31
CA2658246A1 (en) 2008-01-31
WO2008014457A1 (en) 2008-01-31
ZA200900234B (en) 2010-04-28
JP2009544740A (ja) 2009-12-17
US20110160308A1 (en) 2011-06-30
KR20090034365A (ko) 2009-04-07
MX2009000792A (es) 2009-02-03

Similar Documents

Publication Publication Date Title
AU2001245310B2 (en) Compounds with 5-HT1A activity useful for treating disorders of the outer retina
EP0093380A2 (en) Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
CA2212412A1 (en) Deprenyl compounds for treatment of glaucoma
JP2005104862A (ja) 加齢黄斑変性治療剤
JP2010215667A (ja) 外網膜の疾患を処置する薬剤を製造するためのβ−アドレナリン作用受容体アンタゴニストの使用
CA2347863C (en) Treatment of disorders of the outer retina
CA3164071A1 (en) Compounds for treatment of alzheimer's disease
JP2527513B2 (ja) 炭酸脱水酵素阻害物質とβ−アドレナリン拮抗剤との組合せを含有する眼科薬組成物
AU1373997A (en) Use of polyamine site antagonist for the manufacture of a medicament for the treatment of ischemic disorders of the eye
US20110160308A1 (en) Use of Monoamine Oxidase Inhibitors to Treat Outer Retina Disorders
Epner Treatment of Chemical Ocular Injury
MXPA01004175A (en) Treatment of disorders of the outer retina
Matsuo et al. Inhibition of experimental choroidal neovascularization by an anti-growth agent inhibiting vascular endothelial development
Cheruvu Transscleral drug delivery: Role of physiological, physico-chemical and pathological factors in delivering drugs to the posterior segment of eye
JPWO2001058487A1 (ja) 視神経疾患及び網膜疾患の治療及び/または予防剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20090729